Digital Content 
NEWS #PharmaBuzz
10 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/10/3007559/0/en/Arvinas-Updates-Guidance-for-First-and-Second-Line-Phase-3-Combination-Trials-with-Vepdegestrant-Highlights-Upcoming-Milestones-and-Provides-Corporate-Update.html
11 Dec 2024
// PRESS RELEASE
https://www.pfizer.com/news/press-release/press-release-detail/arvinas-and-pfizer-announce-initial-phase-1b-data-tactive-u
25 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/25/2987123/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-San-Antonio-Breast-Cancer-Symposium.html
18 May 2024
// INDINPHARMAPOST
https://www.indianpharmapost.com/diagnostic-center/arvinas-and-pfizer-announce-updated-clinical-data-from-phase-1b-trial-of-vepdegestrant-in-combination-with-palbociclib-15660
16 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/16/2883219/0/en/Arvinas-and-Pfizer-Announce-Updated-Clinical-Data-from-Phase-1b-Trial-of-Vepdegestrant-in-Combination-with-Palbociclib-IBRANCE.html
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879260/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-European-Society-for-Medical-Oncology-ESMO-Breast-Cancer-Annual-Congress.html
Share 